Company / CapEx per Share
Zenas BioPharma, Inc. CapEx per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.00
FY2025
5-year range
$0.00 / $0.01
FY2023-FY2025
Trend
-96.0%
vs FY2024
Sector context
#178 of 192
Health Care
What the data says
Among 192 Health Care companies, Zenas BioPharma, Inc. is in the bottom 7% for capex per share. Declined from $0.01 to $0.00 over the past 2 years.
Based on SEC 10-K filings.
0.00 in FY2025.
Declined from $0.01 to $0.00 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 7% in Health CareTop 93% of 192This company $0.00 Sector average $3.54
▼
-100.0% below sector average
Key checks
Key Insights
- In FY2025, capex per share decreased 96.0% year-over-year.
- Ranks #178 out of 192 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.51 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.00 | -96.0% |
| FY2024 | $0.01 | -2.9% |
| FY2023 | $0.01 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026